Amicus Therapeutics Gross Margin 2010-2025 | FOLD

Current and historical gross margin for Amicus Therapeutics (FOLD) over the last 10 years. The current gross profit margin for Amicus Therapeutics as of March 31, 2025 is %.
Amicus Therapeutics Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2025-03-31 $0.54B $0.49B 90.44%
2024-12-31 $0.53B $0.48B 89.79%
2024-09-30 $0.49B $0.44B 89.88%
2024-06-30 $0.46B $0.41B 89.91%
2024-03-31 $0.42B $0.38B 89.62%
2023-12-31 $0.40B $0.36B 90.50%
2023-09-30 $0.37B $0.34B 90.35%
2023-06-30 $0.35B $0.31B 88.60%
2023-03-31 $0.34B $0.30B 88.72%
2022-12-31 $0.33B $0.29B 88.18%
2022-09-30 $0.32B $0.29B 88.27%
2022-06-30 $0.32B $0.29B 88.82%
2022-03-31 $0.32B $0.28B 88.68%
2021-12-31 $0.31B $0.27B 88.85%
2021-09-30 $0.29B $0.26B 87.76%
2021-06-30 $0.28B $0.25B 88.61%
2021-03-31 $0.27B $0.24B 88.72%
2020-12-31 $0.26B $0.23B 88.12%
2020-09-30 $0.25B $0.22B 88.57%
2020-06-30 $0.23B $0.20B 88.55%
2020-03-31 $0.21B $0.18B 88.04%
2019-12-31 $0.18B $0.16B 87.91%
2019-09-30 $0.16B $0.14B 87.50%
2019-06-30 $0.13B $0.11B 85.61%
2019-03-31 $0.11B $0.09B 84.40%
2018-12-31 $0.09B $0.08B 82.61%
2018-09-30 $0.07B $0.06B 81.08%
2018-06-30 $0.06B $0.05B 82.81%
2018-03-31 $0.05B $0.04B 82.00%
2017-12-31 $0.04B $0.03B 81.08%
2017-09-30 $0.03B $0.02B 80.00%
2017-06-30 $0.02B $0.01B 81.25%
2014-09-30 $0.00B 0 0.00%
2014-06-30 $0.00B 0 0.00%
2013-09-30 $0.00B 0 0.00%
2012-12-31 $0.02B $0.02B 100.00%
2012-06-30 $0.03B $0.03B 100.00%
2012-03-31 $0.02B $0.02B 100.00%
2011-12-31 $0.02B $0.02B 100.00%
2009-12-31 $0.06B $0.06B 100.00%
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $1.940B $0.528B
Amicus Therapeutics, Inc. is a global patient-centric biotechnology company engaged in the discovery, development and commercialization of a diverse set of novel treatments for patients living with rare metabolic diseases.?The company has one marketed medicine in its portfolio named Galafold which is the first and the only approved oral precision medicine for patients living with Fabry disease, having amenable genetic variants. Migalastat is a potent orally available inhibitor of alpha-Gal A.?The drug was granted an accelerated approval by the FDA for treating adult patients with a confirmed diagnosis of Fabry disease and an amenable genetic variant. Galafold is the first and only oral therapy approved in the EU for the long-term treatment of adolescents with Fabry disease.?The lead pipeline candidate in the company's portfolio is AT-GAA, a differentiated biologic for Pompe disease. The company has one gene-therapy program in its pipeline CLN3, a type of Batten disease, being evaluated in a phase I/II study.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) GB $222.705B 16.62
Amgen (AMGN) US $161.511B 14.47
Gilead Sciences (GILD) US $142.480B 14.80
Vertex Pharmaceuticals (VRTX) US $123.142B 0.00
Bristol Myers Squibb (BMY) US $98.742B 6.61
GSK (GSK) GB $81.034B 9.70
CSL (CSLLY) AU $78.181B 0.00
Regeneron Pharmaceuticals (REGN) US $60.435B 14.67
Alnylam Pharmaceuticals (ALNY) US $42.069B 0.00
Argenex SE (ARGX) NL $34.395B 93.89
BioNTech SE (BNTX) DE $27.386B 0.00
Royalty Pharma (RPRX) US $20.308B 8.58
Biogen (BIIB) US $19.830B 8.55
Insmed (INSM) US $18.338B 0.00
Illumina (ILMN) US $15.838B 30.05
Genmab (GNMSF) DK $14.044B 14.36
Genmab (GMAB) DK $14.024B 15.73
Incyte (INCY) US $13.616B 103.44
Moderna (MRNA) US $13.258B 0.00
Exelixis (EXEL) US $12.318B 20.91
BioMarin Pharmaceutical (BMRN) US $11.280B 18.32
QIAGEN (QGEN) NL $10.792B 21.00
Ascendis Pharma (ASND) DK $10.789B 0.00
Swedish Orphan Biovitrum (BIOVF) SE $10.413B 26.59
Exact Sciences (EXAS) US $10.058B 0.00
Verona Pharma American Depositary Share (VRNA) GB $8.926B 0.00
Bio-Techne Corp (TECH) US $8.530B 31.82
Blueprint Medicines (BPMC) US $8.352B 0.00
Regencell Bioscience Holdings (RGC) HK $8.191B 0.00
Roivant Sciences (ROIV) GB $7.865B 0.00
Repligen (RGEN) US $7.529B 84.28
Anbio Biotechnology (NNNN) DE $7.300B 0.00
Legend Biotech (LEGN) US $7.297B 0.00
Revolution Medicines (RVMD) US $7.171B 0.00
Halozyme Therapeutics (HALO) US $7.101B 13.59
Jazz Pharmaceuticals (JAZZ) IE $6.806B 6.68
Bio-Rad Laboratories (BIO.B) US $6.805B 23.68
Guardant Health (GH) US $6.354B 0.00
TG Therapeutics (TGTX) US $5.980B 156.96
Nuvalent (NUVL) US $5.893B 0.00
Rhythm Pharmaceuticals (RYTM) US $5.665B 0.00
Axsome Therapeutics (AXSM) US $5.452B 0.00
Telix Pharmaceuticals (TLX) AU $5.448B 0.00
CRISPR Therapeutics AG (CRSP) CH $5.095B 0.00
Alkermes (ALKS) IE $5.023B 13.48
Vaxcyte (PCVX) US $4.675B 0.00
ADMA Biologics Inc (ADMA) US $4.409B 32.98
Cytokinetics (CYTK) US $4.370B 0.00
Krystal Biotech (KRYS) US $4.327B 33.35
Zealand Pharma (ZLDPF) DK $4.230B 0.00
Akero Therapeutics (AKRO) US $4.145B 0.00
PTC Therapeutics (PTCT) US $3.925B 6.83
Metsera (MTSR) US $3.825B 0.00
Merus (MRUS) NL $3.814B 0.00
Arcellx (ACLX) US $3.795B 0.00
Avidity Biosciences (RNA) US $3.793B 0.00
Zai Lab (ZLAB) CN $3.786B 0.00
ACADIA Pharmaceuticals (ACAD) US $3.692B 32.44
Scholar Rock Holding (SRRK) US $3.619B 0.00
Ascentage Pharma Group - (AAPG) CN $3.549B 0.00
Viking Therapeutics (VKTX) US $3.514B 0.00
Protagonist Therapeutics (PTGX) US $3.274B 70.43
MoonLake Immunotherapeutics (MLTX) CH $3.129B 0.00
Immunovant (IMVT) US $2.994B 0.00
Kymera Therapeutics (KYMR) US $2.944B 0.00
Ultragenyx Pharmaceutical (RARE) US $2.934B 0.00
HUTCHMED (China) (HCM) HK $2.784B 0.00
Alvotech (ALVO) LU $2.632B 15.05
Mirum Pharmaceuticals (MIRM) US $2.626B 0.00
Arrowhead Pharmaceuticals (ARWR) US $2.605B 0.00
ImmunityBio (IBRX) US $2.533B 0.00
Xenon Pharmaceuticals (XENE) CA $2.531B 0.00
Apellis Pharmaceuticals (APLS) US $2.455B 0.00
Ligand Pharmaceuticals (LGND) US $2.411B 0.00
Recursion Pharmaceuticals (RXRX) US $2.323B 0.00
Twist Bioscience (TWST) US $2.305B 0.00
Agios Pharmaceuticals (AGIO) US $2.289B 0.00
Bavarian Nordic (BVNRY) DK $2.252B 11.90
Denali Therapeutics (DNLI) US $2.230B 0.00
Beam Therapeutics (BEAM) US $2.215B 0.00
Kiniksa Pharmaceuticals (KNSA) GB $2.113B 0.00
Vericel (VCEL) US $2.076B 1374.33
CG Oncology (CGON) US $2.066B 0.00
NovoCure (NVCR) JE $2.058B 0.00
Disc Medicine (IRON) US $2.009B 0.00
IDEAYA Biosciences (IDYA) US $1.997B 0.00
Belite Bio (BLTE) US $1.975B 0.00
Harmony Biosciences Holdings (HRMY) US $1.971B 13.10
Sarepta Therapeutics (SRPT) US $1.874B 0.00
Certara (CERT) US $1.866B 34.85
Adaptive Biotechnologies (ADPT) US $1.835B 0.00
Arcutis Biotherapeutics (ARQT) US $1.820B 0.00
Immunocore Holdings (IMCR) GB $1.781B 0.00
Apogee Therapeutics (APGE) US $1.776B 0.00
Tarsus Pharmaceuticals (TARS) US $1.729B 0.00
89BIO (ETNB) US $1.574B 0.00
GRAIL (GRAL) US $1.561B 0.00
Vera Therapeutics (VERA) US $1.553B 0.00
Biohaven (BHVN) US $1.535B 0.00
Janux Therapeutics (JANX) US $1.515B 0.00
Celldex Therapeutics (CLDX) US $1.506B 0.00
Travere Therapeutics (TVTX) US $1.470B 0.00
Edgewise Therapeutics (EWTX) US $1.459B 0.00
ANI Pharmaceuticals (ANIP) US $1.432B 14.75
Mesoblast (MESO) AU $1.408B 0.00
Viridian Therapeutics (VRDN) US $1.398B 0.00
Dynavax Technologies (DVAX) US $1.309B 77.86
AbCellera Biologics (ABCL) CA $1.268B 0.00
Intellia Therapeutics (NTLA) US $1.260B 0.00
WAVE Life Sciences (WVE) SG $1.237B 0.00
Cogent Biosciences (COGT) US $1.235B 0.00
CureVac (CVAC) DE $1.223B 5.92
Liquidia Technologies (LQDA) US $1.210B 0.00
MannKind (MNKD) US $1.155B 23.75
Novavax (NVAX) US $1.150B 2.68
Pacira BioSciences (PCRX) US $1.097B 10.44
Structure Therapeutics (GPCR) US $1.084B 0.00
Pharvaris (PHVS) NL $1.037B 0.00
Cidara Therapeutics (CDTX) US $1.026B 0.00
Praxis Precision Medicines (PRAX) US $1.025B 0.00
Arcus Biosciences (RCUS) US $1.010B 0.00
MiMedx (MDXG) US $1.001B 24.21
Oric Pharmaceuticals (ORIC) US $0.976B 0.00
Nurix Therapeutics (NRIX) US $0.969B 0.00
LENZ Therapeutics (LENZ) US $0.964B 0.00
NeoGenomics (NEO) US $0.964B 0.00
Spyre Therapeutics (SYRE) US $0.962B 0.00
Anavex Life Sciences (AVXL) US $0.954B 0.00
Mineralys Therapeutics (MLYS) US $0.954B 0.00
Zymeworks (ZYME) US $0.952B 0.00
BGM Group (BGM) CN $0.939B 0.00
Niagen Bioscience (NAGE) US $0.929B 131.00
Sionna Therapeutics (SION) US $0.924B 0.00
Sana Biotechnology (SANA) US $0.915B 0.00
Geron (GERN) US $0.879B 0.00
Syndax Pharmaceuticals (SNDX) US $0.845B 0.00
GH Research (GHRS) IE $0.835B 0.00
Replimune (REPL) US $0.830B 0.00
Vir Biotechnology (VIR) US $0.820B 0.00
UniQure (QURE) NL $0.815B 0.00
Basilea Pharmaceutica AG (BPMUF) CH $0.808B 0.00
Oculis Holding AG (OCS) CH $0.803B 0.00
CorMedix Inc (CRMD) US $0.794B 53.23
Nuvation Bio (NUVB) US $0.786B 0.00
Immunome (IMNM) US $0.779B 0.00
Pharming Group (PHGUF) NL $0.772B 0.00
AnaptysBio (ANAB) US $0.767B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) US $0.761B 0.00
ArriVent BioPharma (AVBP) US $0.754B 0.00
Trevi Therapeutics (TRVI) US $0.752B 0.00
Gyre Therapeutics (GYRE) US $0.732B 195.25
Immatics (IMTX) DE $0.729B 0.00
Day One Biopharmaceuticals (DAWN) US $0.729B 0.00
MeiraGTx Holdings (MGTX) US $0.693B 0.00
Jyong Biotech (MENS) TW $0.693B 0.00
Maze Therapeutics (MAZE) US $0.685B 0.00
Pharming Group (PHAR) NL $0.680B 0.00
Phathom Pharmaceuticals (PHAT) US $0.677B 0.00
Urogen Pharma (URGN) US $0.675B 0.00
Dianthus Therapeutics (DNTH) US $0.663B 0.00
Tango Therapeutics (TNGX) US $0.662B 0.00
Autolus Therapeutics (AUTL) GB $0.660B 0.00
Stoke Therapeutics (STOK) US $0.657B 15.24
Sinovac Biotech (SVA) CN $0.645B 0.00
Iovance Biotherapeutics (IOVA) US $0.644B 0.00
Upstream Bio (UPB) US $0.637B 0.00
Ginkgo Bioworks Holdings (DNA) US $0.632B 0.00
Prime Medicine (PRME) US $0.631B 0.00
Arbutus Biopharma (ABUS) US $0.628B 0.00
Mind Medicine (MindMed) (MNMD) US $0.612B 0.00
Keros Therapeutics (KROS) US $0.588B 0.00
Sage Therapeutics (SAGE) US $0.577B 0.00
Arvinas (ARVN) US $0.576B 0.00
Castle Biosciences (CSTL) US $0.573B 38.90
Precigen (PGEN) US $0.564B 0.00
Rapport Therapeutics (RAPP) US $0.561B 0.00
Bicycle Therapeutics (BCYC) GB $0.560B 0.00
Kura Oncology (KURA) US $0.551B 0.00
Tyra Biosciences (TYRA) US $0.544B 0.00
Bicara Therapeutics (BCAX) US $0.541B 0.00
Abivax SA (ABVX) FR $0.527B 0.00
Opthea (OPT) AU $0.525B 0.00
Septerna (SEPN) US $0.520B 0.00
Celcuity (CELC) US $0.516B 0.00
Myriad Genetics (MYGN) US $0.507B 0.00
Oxford BioMedica (OXBDF) GB $0.505B 0.00
Zenas BioPharma (ZBIO) US $0.505B 0.00
Fortrea Holdings (FTRE) US $0.477B 13.18
ATyr Pharma (ATYR) US $0.474B 0.00
Cullinan Therapeutics (CGEM) US $0.463B 0.00
Kamada (KMDA) IL $0.461B 27.66
REGENXBIO (RGNX) US $0.454B 0.00
Cytek Biosciences (CTKB) US $0.451B 0.00
Rezolute (RZLT) US $0.449B 0.00
Fulcrum Therapeutics (FULC) US $0.432B 0.00
Erasca (ERAS) US $0.431B 0.00
PureTech Health (PRTC) US $0.430B 0.00
Terns Pharmaceuticals (TERN) US $0.425B 0.00
Solid Biosciences (SLDB) US $0.420B 0.00
Eton Pharmaceuticals (ETON) US $0.417B 0.00
MBX Biosciences (MBX) US $0.414B 0.00
Lexicon Pharmaceuticals (LXRX) US $0.408B 0.00
Tectonic Therapeutic (TECX) US $0.406B 0.00
Emergent Biosolutions (EBS) US $0.398B 0.00
Compass Therapeutics (CMPX) US $0.394B 0.00
Arcturus Therapeutics Holdings (ARCT) US $0.393B 0.00
ITeos Therapeutics (ITOS) US $0.391B 0.00
Humacyte (HUMA) US $0.389B 0.00
Vigil Neuroscience (VIGL) US $0.383B 0.00
Astria Therapeutics (ATXS) US $0.376B 0.00
Benitec Biopharma (BNTC) US $0.362B 0.00
Amarin (AMRN) IE $0.359B 0.00
Prothena (PRTA) IE $0.354B 0.00
Cartesian Therapeutics (RNAC) US $0.351B 0.00
Absci (ABSI) US $0.348B 0.00
Aura Biosciences (AURA) US $0.340B 0.00
Rocket Pharmaceuticals (RCKT) US $0.337B 0.00
Ocugen (OCGN) US $0.336B 0.00
XOMA Royalty (XOMA) US $0.334B 0.00
Olema Pharmaceuticals (OLMA) US $0.332B 0.00
ADC Therapeutics SA (ADCT) CH $0.327B 0.00
Northwest Biotherapeutics (NWBO) US $0.325B 0.00
Lifecore Biomedical (LFCR) US $0.325B 0.00
Monte Rosa Therapeutics (GLUE) US $0.324B 65.75
Atea Pharmaceuticals (AVIR) US $0.323B 0.00
Inventiva S.A (IVA) FR $0.323B 0.00
Zhengye Biotechnology Holding (ZYBT) CN $0.316B 0.00
Neurogene (NGNE) US $0.313B 0.00
Gossamer Bio (GOSS) US $0.309B 0.00
Candel Therapeutics (CADL) US $0.308B 0.00
Annexon (ANNX) US $0.307B 0.00
Sagimet Biosciences (SGMT) US $0.304B 0.00
Inhibrx Biosciences (INBX) US $0.304B 0.18
Foghorn Therapeutics (FHTX) US $0.301B 0.00
Abeona Therapeutics (ABEO) US $0.299B 0.00
Palvella Therapeutics (PVLA) US $0.298B 0.00
DBV Technologies S.A (DBVT) FR $0.297B 0.00
Vanda Pharmaceuticals (VNDA) US $0.294B 0.00
Corvus Pharmaceuticals (CRVS) US $0.290B 0.00
Vor Biopharma (VOR) $0.289B 0.00
Alpha Teknova (TKNO) US $0.277B 0.00
Cardiff Oncology (CRDF) US $0.277B 0.00
Allogene Therapeutics (ALLO) US $0.276B 0.00
Aardvark Therapeutics (AARD) US $0.273B 0.00
Mereo BioPharma Group - (MREO) GB $0.269B 0.00
Crescent Biopharma (CBIO) US $0.264B 0.00
Verastem (VSTM) US $0.260B 0.00
Codexis (CDXS) US $0.258B 0.00
Entrada Therapeutics (TRDA) US $0.257B 8.35
Editas Medicine (EDIT) US $0.256B 0.00
Adherex Technologies (FENC) US $0.250B 0.00
ProQR Therapeutics (PRQR) NL $0.248B 0.00
Third Harmonic Bio (THRD) US $0.246B 0.00
MaxCyte (MXCT) US $0.243B 0.00
Prima BioMed (IMMP) AU $0.240B 0.00
Kodiak Sciences (KOD) US $0.237B 0.00
ScPharmaceuticals (SCPH) US $0.236B 0.00
Monopar Therapeutics (MNPR) US $0.234B 0.00
Citius Oncology (CTOR) US $0.233B 0.00
Design Therapeutics (DSGN) US $0.229B 0.00
Semper Paratus Acquisition (TVGN) US $0.224B 0.00
Adocia (ADOCY) FR $0.216B 0.00
Tvardi Therapeutics (TVRD) US $0.212B 0.00
CARGO Therapeutics (CRGX) US $0.212B 0.00
AC Immune (ACIU) CH $0.212B 0.00
CytomX Therapeutics (CTMX) US $0.210B 5.42
BioStem Technologies (BSEM) $0.208B 8.47
Eledon Pharmaceuticals (ELDN) US $0.207B 0.00
Y-mAbs Therapeutics (YMAB) US $0.205B 0.00
Ventyx Biosciences (VTYX) US $0.202B 0.00
Eupraxia Pharmaceuticals (EPRX) CA $0.202B 0.00
Voyager Therapeutics (VYGR) US $0.196B 0.00
Alumis (ALMS) US $0.194B 0.00
SELLAS Life Sciences (SLS) US $0.189B 0.00
EnGene Holdings (ENGN) CA $0.188B 0.00
GENFIT S.A (GNFT) FR $0.188B 0.00
Bright Minds Biosciences (DRUG) US $0.183B 0.00
Alpha Cognition (ACOG) CA $0.176B 0.00
Instil Bio (TIL) US $0.176B 0.00
Puma Biotechnology (PBYI) US $0.175B 4.57
Alector (ALEC) US $0.172B 0.00
Tiziana Life Sciences (TLSA) GB $0.172B 0.00
Neumora Therapeutics (NMRA) US $0.171B 0.00
Nuvectis Pharma (NVCT) US $0.171B 0.00
Anika Therapeutics (ANIK) US $0.169B 0.00
BioAge Labs (BIOA) US $0.168B 0.00
I-Mab (IMAB) US $0.167B 0.00
Innate Pharma S.A (IPHA) FR $0.167B 0.00
Agenus (AGEN) US $0.162B 0.00
Caribou Biosciences (CRBU) US $0.162B 0.00
Spero Therapeutics (SPRO) US $0.159B 0.00
DiaMedica Therapeutics (DMAC) US $0.157B 0.00
Immuneering (IMRX) US $0.156B 0.00
Black Diamond Therapeutics (BDTX) US $0.156B 45.67
Kyverna Therapeutics (KYTX) US $0.154B 0.00
Compugen (CGEN) IL $0.151B 0.00
Greenwich LifeSciences (GLSI) US $0.150B 0.00
Enanta Pharmaceuticals (ENTA) US $0.149B 0.00
Cuprina Holdings (Cayman) (CUPR) SG $0.149B 0.00
Theratechnologies (THTX) CA $0.145B 0.00
Molecular Partners AG (MOLN) CH $0.143B 0.00
Rapt Therapeutics (RAPT) US $0.143B 0.00
C4 Therapeutics (CCCC) US $0.141B 0.00
Milestone Pharmaceuticals (MIST) CA $0.137B 0.00
23andMe Holding (MEHCQ) US $0.136B 0.00
Fate Therapeutics (FATE) US $0.133B 0.00
Elicio Therapeutics (ELTX) US $0.132B 0.00
Genelux (GNLX) US $0.130B 0.00
Seer (SEER) US $0.129B 0.00
Nkarta (NKTX) US $0.128B 0.00
Skye Bioscience (SKYE) US $0.122B 0.00
Actuate Therapeutics (ACTU) US $0.121B 0.00
BioHarvest Sciences (BHST) CA $0.119B 0.00
Sangamo Therapeutics (SGMO) US $0.117B 0.00
Orchestra BioMed Holdings (OBIO) US $0.115B 0.00
Tenaya Therapeutics (TNYA) US $0.112B 0.00
TuHURA Biosciences (HURA) US $0.110B 0.00
Seres Therapeutics (MCRB) US $0.108B 0.00
Coya Therapeutics (COYA) US $0.106B 0.00
HilleVax (HLVX) US $0.105B 0.00
Oncolytics Biotech (ONCY) CA $0.105B 0.00
Contineum Therapeutics (CTNM) US $0.104B 0.00
TScan Therapeutics (TCRX) US $0.104B 0.00
ANIXA BIOSCIENCES INC (ANIX) US $0.101B 0.00
Elutia (ELUT) US $0.101B 0.00
Coherus Oncology (CHRS) US $0.101B 0.00
Zentalis Pharmaceuticals (ZNTL) US $0.099B 0.00
OKYO Pharma (OKYO) $0.097B 0.00
Prenetics Global (PRE) HK $0.095B 0.00
Zura Bio (ZURA) US $0.095B 0.00
Nautilus Biotechnology (NAUT) US $0.095B 0.00
Whitehawk Therapeutics (WHWK) US $0.093B 0.00
IO Biotech (IOBT) DK $0.092B 0.00
Cellectis S.A (CLLS) FR $0.092B 0.00
Adagene (ADAG) CN $0.091B 0.00
Climb Bio (CLYM) US $0.091B 0.00
BeyondSpring (BYSI) US $0.091B 0.00
XBiotech (XBIT) US $0.090B 0.00
Invivyd (IVVD) US $0.089B 0.00
Cabaletta Bio (CABA) US $0.088B 0.00
Pliant Therapeutics (PLRX) US $0.086B 0.00
EXoZymes (EXOZ) US $0.084B 0.00
Entera Bio (ENTX) IL $0.084B 0.00
TELA Bio (TELA) US $0.082B 0.00
IGM Biosciences (IGMS) US $0.081B 0.00
Quince Therapeutics (QNCX) US $0.081B 0.00
Immunic (IMUX) US $0.080B 0.00
Acumen Pharmaceuticals (ABOS) US $0.079B 0.00
Immix Biopharma (IMMX) US $0.076B 0.00
Forte Biosciences (FBRX) US $0.075B 0.00
Anebulo Pharmaceuticals (ANEB) US $0.073B 0.00
Adaptimmune Therapeutics (ADAP) GB $0.073B 0.00
Biomea Fusion (BMEA) US $0.073B 0.00
Genenta Science S.p.A (GNTA) IT $0.071B 0.00
VistaGen Therapeutics (VTGN) US $0.071B 0.00
Alto Neuroscience (ANRO) US $0.070B 0.00
Sutro Biopharma (STRO) US $0.069B 0.00
Clearside Biomedical (CLSD) US $0.068B 0.00
Oncobiologics (OTLK) US $0.068B 0.00
Ikena Oncology (IKNA) US $0.067B 0.00
Repare Therapeutics (RPTX) CA $0.067B 0.00
Opus Genetics (IRD) US $0.067B 0.00
Connect Biopharma Holdings (CNTB) US $0.064B 0.00
CervoMed (CRVO) US $0.063B 0.00
MediciNova (MNOV) US $0.062B 0.00
Adicet Bio (ACET) US $0.061B 0.00
Senti Biosciences (SNTI) US $0.061B 0.00
InflaRx (IFRX) DE $0.060B 0.00
Cue Biopharma (CUE) US $0.060B 0.00
PDS Biotechnology (PDSB) US $0.059B 0.00
Fortress Biotech (FBIO) US $0.059B 0.00
Applied Therapeutics (APLT) US $0.059B 0.00
ABVC BioPharma (ABVC) US $0.057B 0.00
Adverum Biotechnologies (ADVM) US $0.057B 0.00
Atara Biotherapeutics (ATRA) US $0.057B 0.00
VTv Therapeutics (VTVT) US $0.056B 0.00
Adlai Nortye (ANL) KY $0.056B 0.00
Annovis Bio (ANVS) US $0.056B 0.00
Quantum Biopharma (QNTM) CA $0.055B 0.00
Aligos Therapeutics (ALGS) US $0.054B 0.00
Precision BioSciences (DTIL) US $0.054B 0.00
Jasper Therapeutics (JSPR) US $0.053B 0.00
INmune Bio (INMB) US $0.053B 0.00
Earth Science Tech (ETST) US $0.052B 0.00
Celularity (CELU) US $0.052B 0.00
ZIVO Bioscience (ZIVO) US $0.051B 0.00
Renovaro (RENB) US $0.051B 0.00
Inovio Pharmaceuticals (INO) US $0.051B 0.00
RenovoRx (RNXT) US $0.049B 0.00
Werewolf Therapeutics (HOWL) US $0.048B 0.00
Mersana Therapeutics (MRSN) US $0.047B 0.00
Kalaris Therapeutics (KLRS) US $0.047B 0.00
Exicure (XCUR) US $0.046B 0.00
Scilex Holding (SCLX) US $0.045B 0.00
Medicus Pharma (MDCX) US $0.045B 0.00
KALA BIO (KALA) US $0.045B 0.00
Artiva Biotherapeutics (ARTV) US $0.044B 0.00
Cognition Therapeutics (CGTX) US $0.043B 0.00
Grace Therapeutics (GRCE) CA $0.043B 0.00
Barinthus Biotherapeutics (BRNS) GB $0.043B 0.00
Pluri (PLUR) IL $0.042B 0.00
PepGen (PEPG) US $0.041B 0.00
Q32 Bio (QTTB) US $0.041B 0.00
Xilio Therapeutics (XLO) US $0.039B 0.00
Rani Therapeutics Holdings (RANI) US $0.038B 0.00
Lantern Pharma (LTRN) US $0.038B 0.00
Shattuck Labs (STTK) US $0.037B 0.00
Akari Therapeutics (AKTX) GB $0.037B 0.00
Hyperion DeFi (HYPD) US $0.036B 0.00
LAVA Therapeutics (LVTX) NL $0.036B 0.00
Kezar Life Sciences (KZR) US $0.035B 0.00
Alterity Therapeutics - (ATHE) AU $0.034B 0.00
OnKure Therapeutics (OKUR) US $0.034B 0.00
Estrella Immunopharma (ESLA) US $0.033B 0.00
Coeptis Therapeutics Holdings (COEP) US $0.033B 0.00
Radiopharm Theranostics - (RADX) AU $0.033B 0.00
Rein Therapeutics (RNTX) US $0.033B 0.00
Biodexa Pharmaceuticals (BDRX) GB $0.033B 0.00
AN2 Therapeutics (ANTX) US $0.032B 0.00
Clene (CLNN) US $0.031B 0.00
CAMP4 Therapeutics (CAMP) US $0.031B 0.00
Femasys (FEMY) US $0.031B 0.00
MiNK Therapeutics (INKT) US $0.031B 0.00
Dyadic (DYAI) US $0.030B 0.00
Ovid Therapeutics (OVID) US $0.030B 0.00
NeuroSense Therapeutics (NRSN) IL $0.029B 0.00
ALX Oncology Holdings (ALXO) US $0.027B 0.00
Boundless Bio (BOLD) US $0.026B 0.00
FibroBiologics (FBLG) US $0.026B 0.00
Cadrenal Therapeutics (CVKD) US $0.026B 0.00
Generation Bio (GBIO) US $0.025B 0.00
Passage Bio (PASG) US $0.025B 0.00
Tenax Therapeutics (TENX) US $0.024B 0.00
Lisata Therapeutics (LSTA) US $0.024B 0.00
SAB Biotherapeutics (SABS) US $0.023B 0.00
CalciMedica (CALC) US $0.023B 0.00
BioAtla (BCAB) US $0.023B 0.00
Elevation Oncology (ELEV) US $0.022B 0.00
Longeveron (LGVN) US $0.022B 0.00
Chemomab Therapeutics (CMMB) IL $0.022B 0.00
Dare Bioscience (DARE) US $0.021B 0.00
Aytu BioPharma (AYTU) US $0.021B 0.00
MIRA Pharmaceuticals (MIRA) US $0.020B 0.00
Curis (CRIS) US $0.020B 0.00
Hoth Therapeutics (HOTH) US $0.020B 0.00
Cingulate (CING) US $0.019B 0.00
CollPlant Biotechnologies (CLGN) IL $0.018B 0.00
Gelteq (GELS) AU $0.018B 0.00
Aspire Biopharma Holdings (ASBP) US $0.017B 0.00
Advanced Biomed (ADVB) US $0.017B 0.00
Beyond Air (XAIR) US $0.017B 0.00
Sonnet BioTherapeutics Holdings (SONN) US $0.017B 0.00
Rallybio (RLYB) US $0.016B 0.00
Athira Pharma (ATHA) US $0.016B 0.00
Allarity Therapeutics (ALLR) US $0.016B 0.00
Lexaria Bioscience (LEXX) CA $0.016B 0.00
Artelo Biosciences (ARTL) US $0.016B 0.00
HOOKIPA Pharma (HOOK) US $0.015B 0.00
Leap Therapeutics (LPTX) US $0.015B 0.00
Acurx Pharmaceuticals (ACXP) US $0.015B 0.00
Edesa Biotech (EDSA) CA $0.015B 0.00
Synlogic (SYBX) US $0.015B 0.00
Neuphoria Therapeutics (NEUP) AU $0.014B 0.00
MetaVia (MTVA) US $0.014B 0.00
BRIACELL THERAP (BCTX) CA $0.014B 0.00
IBio (IBIO) US $0.014B 0.00
BioCardia (BCDA) US $0.013B 0.00
Promis Neurosciences (PMN) CA $0.013B 0.00
NextCure (NXTC) US $0.013B 0.00
Equillium (EQ) US $0.012B 0.00
Bolt Biotherapeutics (BOLT) US $0.012B 0.00
BioXcel Therapeutics (BTAI) US $0.012B 0.00
Biorestorative Therapies (BRTX) US $0.012B 0.00
Brainstorm Cell Therapeutics (BCLI) US $0.012B 0.00
Abpro Holdings (ABP) US $0.012B 0.00
Mustang Bio (MBIO) US $0.012B 0.00
Sensei Biotherapeutics (SNSE) US $0.011B 0.00
Bionano Genomics (BNGO) US $0.011B 0.00
Cyclerion Therapeutics (CYCN) US $0.011B 0.00
Imunon (IMNN) US $0.011B 0.00
Lixte Biotechnology Holdings (LIXT) US $0.011B 0.00
Synaptogenix (TAOX) US $0.011B 0.00
COSCIENS Biopharma (CSCI) CA $0.011B 0.00
GeoVax Labs (GOVX) US $0.011B 0.00
Novogen (KZIA) AU $0.010B 0.00
IMMURON (IMRN) AU $0.010B 0.00
LakeShore Biopharma (LSB) CN $0.010B 0.00
Aprea Therapeutics (APRE) US $0.010B 0.00
GENPREX (GNPX) US $0.010B 0.00
Dogwood Therapeutics (DWTX) US $0.010B 0.00
X4 Pharmaceuticals (XFOR) US $0.009B 0.00
Jade Biosciences (JBIO) US $0.009B 0.00
BioAffinity Technologies (BIAF) US $0.009B 0.00
Turnstone Biologics (TSBX) US $0.009B 0.00
Biofrontera (BFRI) US $0.008B 0.00
Intensity Therapeutics (INTS) US $0.008B 0.00
Evogene (EVGN) IL $0.008B 0.00
Moleculin Biotech (MBRX) US $0.008B 0.00
GT Biopharma (GTBP) US $0.008B 0.00
Cardio Diagnostics Holdings (CDIO) US $0.007B 0.00
Creative Medical Technology Holdings (CELZ) US $0.007B 0.00
Sunshine Biopharma (SBFM) US $0.007B 0.00
Silexion Therapeutics Corp (SLXN) IL $0.007B 0.00
IN8bio (INAB) US $0.007B 0.00
Mainz Biomed (MYNZ) DE $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.007B 0.00
Arcadia Biosciences (RKDA) US $0.007B 0.00
Portage Biotech (PRTG) $0.006B 0.00
HCW Biologics (HCWB) US $0.006B 0.00
Apollomics (APLM) US $0.006B 0.00
180 Life Sciences (ATNF) US $0.005B 0.00
Pasithea Therapeutics (KTTA) US $0.005B 0.00
VivoSim Labs (VIVS) US $0.005B 0.00
CNS Pharmaceuticals (CNSP) US $0.005B 0.00
Ensysce Biosciences (ENSC) US $0.005B 0.00
Avalon GloboCare (ALBT) US $0.005B 0.00
Tharimmune (THAR) US $0.005B 0.00
Dermata Therapeutics (DRMA) US $0.005B 0.00
Galecto (GLTO) DK $0.005B 0.00
Revelation Biosciences (REVB) US $0.004B 0.00
Adial Pharmaceuticals (ADIL) US $0.004B 0.00
Soligenix (SNGX) US $0.004B 0.00
Titan Pharmaceuticals (TTNP) US $0.004B 0.00
Virax Biolabs Group (VRAX) GB $0.004B 0.00
Polyrizon (PLRZ) IL $0.004B 0.00
Palisade Bio (PALI) US $0.004B 0.00
GRI Bio (GRI) US $0.003B 0.00
Purple Biotech (PPBT) IL $0.003B 0.00
Enveric Biosciences (ENVB) US $0.003B 0.00
AquaBounty Technologies (AQB) US $0.003B 0.00
Psyence Biomedical (PBM) CA $0.003B 0.00
Silo Pharma (SILO) US $0.003B 0.00
ZyVersa Therapeutics (ZVSA) US $0.003B 0.00
Alzamend Neuro (ALZN) US $0.002B 0.00
Windtree Therapeutics (WINT) US $0.002B 0.00
Onconetix (ONCO) US $0.002B 0.00
Entero Therapeutics (ENTO) US $0.002B 0.00
Scinai Immunotherapeutics (SCNI) IL $0.002B 0.00
Aptevo Therapeutics (APVO) US $0.002B 0.00
Atrinsic (PTIX) US $0.002B 0.00
Bone Biologics (BBLG) US $0.002B 0.00
NuCana (NCNA) GB $0.000B 0.00
Aceragen (ACGN) US $0.000B 0.00
ARAVIVE, INC (ARAV) US $0.000B 0.00
Clovis Oncology (CLVSQ) US $0.000B 0.00
Cocrystal Pharma (COCP) US $0.000B 0.00
Celyad SA (CYAD) BE $0.000B 0.00
CytoMed Therapeutics (GDTC) SG $0.000B 0.00
Galapagos (GLPG) BE $0.000B 0.00
Motif Bio Plc (MTFB) GB $0.000B 0.00
PDL BioPharma (PDLI) US $0.000B 0.00
Pulmatrix (PULM) US $0.000B 0.00
TFF Pharmaceuticals (TFFP) US $0.000B 0.00
VectivBio Holding AG (VECT) CH $0.000B 0.00